Log in

NASDAQ:PETSPetmed Express Stock Price, Forecast & News

$29.30
-0.08 (-0.27 %)
(As of 04/10/2020 06:18 AM ET)
Add
Compare
Today's Range
$28.63
Now: $29.30
$29.99
50-Day Range
$22.18
MA: $26.97
$30.86
52-Week Range
$15.00
Now: $29.30
$31.87
Volume564,880 shs
Average Volume744,979 shs
Market Capitalization$590.98 million
P/E Ratio23.44
Dividend Yield3.68%
Beta0.41
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. It also sells food, beds, crates, stairs, strollers, and other pet supplies. The company sells its products through its Internet Website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.
Read More
Petmed Express logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 1.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$283.42 million
Cash Flow$1.93 per share
Book Value$6.51 per share

Profitability

Net Income$37.74 million

Miscellaneous

Employees187
Market Cap$590.98 million
Next Earnings Date5/4/2020 (Estimated)
OptionableOptionable

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.


Petmed Express (NASDAQ:PETS) Frequently Asked Questions

How has Petmed Express' stock been impacted by COVID-19 (Coronavirus)?

Petmed Express' stock was trading at $25.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PETS shares have increased by 12.9% and is now trading at $29.30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Petmed Express.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Petmed Express.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) posted its quarterly earnings data on Tuesday, January, 21st. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.04. The business earned $59.92 million during the quarter, compared to the consensus estimate of $61.31 million. Petmed Express had a net margin of 9.28% and a return on equity of 19.91%. The firm's quarterly revenue was down .2% on a year-over-year basis. During the same period last year, the firm earned $0.38 earnings per share. View Petmed Express' earnings history.

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Tuesday, January 21st. Stockholders of record on Monday, February 3rd will be given a dividend of $0.27 per share on Friday, February 14th. This represents a $1.08 annualized dividend and a yield of 3.69%. The ex-dividend date of this dividend is Friday, January 31st. View Petmed Express' dividend history.

What price target have analysts set for PETS?

2 equities research analysts have issued 1 year price targets for Petmed Express' stock. Their forecasts range from $20.00 to $31.00. On average, they expect Petmed Express' share price to reach $25.50 in the next twelve months. This suggests that the stock has a possible downside of 13.0%. View analysts' price targets for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Media headlines about PETS stock have been trending very negative on Friday, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Petmed Express earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutPetmed Express.

Are investors shorting Petmed Express?

Petmed Express saw a drop in short interest in March. As of March 13th, there was short interest totaling 4,831,800 shares, a drop of 8.1% from the February 27th total of 5,260,000 shares. Based on an average daily trading volume, of 492,000 shares, the short-interest ratio is presently 9.8 days. Currently, 24.9% of the shares of the company are short sold. View Petmed Express' Current Options Chain.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), Alibaba Group (BABA), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), Netflix (NFLX), Ford Motor (F), Advanced Micro Devices (AMD) and Cisco Systems (CSCO).

Who are Petmed Express' key executives?

Petmed Express' management team includes the following people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.09%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag and Robert C Schweitzer. View institutional ownership trends for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View insider buying and selling activity for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $29.30.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $590.98 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe. View additional information about Petmed Express.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com/.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.

This page was last updated on 4/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel